Cleared Traditional

K170168 - Masimo Rad-97 and Accessories

K170168 is an FDA 510(k) clearance for Masimo Rad-97 and Accessories, manufactured by Masimo Corporation. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 238-day FDA review.

K170168 · Masimo Corporation · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
238d
Days
Class 2
Risk

K170168 is an FDA 510(k) clearance for the Masimo Rad-97 and Accessories. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on September 14, 2017 after a review of 238 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Masimo Corporation devices

FDA 510(k) Submission Details - K170168

510(k) Number K170168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2017
Decision Date September 14, 2017
Days to Decision 238 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 125d · This submission: 238d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 307
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K170168.
3880 MRI Patient Monitoring System
K172200 · Iradimed Corporation · Oct 2017
SmartLinx Vitals Plus NIBP Module, SmartLinx Vitals Plus License for Spot Monitoring Mode, SmartLinx Vitals Plus Alarm Hub, SmartLinx Vitals Plus License for Advanced Monitoring Mode, Covidien FILAC 3000 - Temperature Module
K171751 · Capsule Technologie Sas · Oct 2017
RVS-100 Vital Signs Monitor
K170538 · Rudolf Riester GmbH · Oct 2017
All-in-One Health Monitor, PC-303
K170047 · Shenzhen Creative Industry Co., Ltd. · Sep 2017
QMAPP Amplifier
K170032 · Fysicon BV · Sep 2017
Accutorr 7/VS-900 Vital Signs Monitor
K170712 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Aug 2017